Skip to main content

Table 1 Baseline characteristics of subjects in the Zinc and Placebo groups

From: Zinc supplementation improves body weight management, inflammatory biomarkers and insulin resistance in individuals with obesity: a randomized, placebo-controlled, double-blind trial

Characteristics

Zinc (n = 18)

Placebo (n = 22)

Age (years)a

35.63 ± 3.2

32.95 ± 1.7

Sex (n/%)

 Male

6 (24%)

8 (32%)

 Female

19 (76%)

17 (68%)

Past experiences with weight-reducing treatment (n/%)

 Yes

15 (60%)

13 (52%)

 No

10 (40%)

12 (48%)

Marital status (n/%)

 Single

8 (32%)

9 (36%)

 Married

17 (68%)

16 (64%)

  1. aValues are mean ± SD